EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Skeletal Class II Malocclusion: From Clinical Treatment Strategies to the Roadmap in Identifying the Genetic Bases of Development in Humans with the Support of the Collaborative Cross Mouse Population

Iqbal M Lone, Osayd Zohud iD, Kareem Midlej, Peter Proff, Nezar Watted, Fuad A Iraqi iD

Journal of Clinical Medicine · 06.08.2023 · 12 (15) · 5148

DOI: 10.3390/jcm12155148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.08.2023. Verfasst von Iqbal M Lone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel-Aviv University, University Hospital of Regensburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depending on how severe it is, malocclusion, which may involve misaligned teeth, jaws, or a combination of the two, can hurt a person’s overall facial aesthetics. The maxillary molar develops before the mandibular molar in class II malocclusion, which affects 15% of the population in the United States. With a retrusive mandible, patients typically have a convex profile. The goal of this study is to classify the skeletal and dental variability present in class II malocclusion, to reduce heterogeneity, present the current clinical treatment strategies, to summarize the previously published findings of genetic analysis, discuss these findings and their constraints, and finally, propose a comprehensive roadmap to facilitate investigations aimed at determining the genetic bases of malocclusion development using a variety of genomic approaches. To further comprehend the hereditary components involved in the onset and progression of class II malocclusion, a novel animal model for class II malocclusion should be developed while considering the variety of the human population. To overcome the constraints of the previous studies, here, we propose to conduct novel research on humans with the support of mouse models to produce contentious findings. We believe that carrying out a genome-wide association study (GWAS) on a large human cohort to search for significant genes and their modifiers; an epigenetics-wide association study (EWAS); RNA-seq analysis; integrating GWAS and the expression of quantitative trait loci (eQTL); and the testing of microRNAs, small RNAs, and long noncoding RNAs in tissues related to the skeletal class II malocclusion (SCIIMO) phenotype, such as mandibular bone, gum, and jaw in humans and the collaborative cross (CC) mouse model, will identify novel genes and genetic factors affecting this phenotype. We anticipate discovering novel genetic elements to advance our knowledge of how this malocclusion phenotype develops and open the venue for the early identification of patients carrying the susceptible genetic factors so that we can offer early prevention treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

collaborative cross mouse modeletiologyquantitative trait lociskeletal class II malocclusiontreatment

Autor:innen und Institutionen

  • Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Orthodontics, University Hospital of Regensburg, 93053 Regensburg, Germany.
  • Center for Dentistry Research and Aesthetics, Jatt 4491800, Israel.
  • Department of Orthodontics, Faculty of Dentistry, Arab America University, Jenin 34567, Palestine.
  • Gathering for Prosperity Initiative, Jatt 4491800, Israel.

ORCID-Profile: Osayd Zohud, Fuad A Iraqi

Förderung

  • Tel-Aviv University
  • University Hospital of Regensburg

Zitieren

APA

Lone, I. M., Zohud, O., Midlej, K., Proff, P., Watted, N., & Iraqi, F. A. (2023). Skeletal Class II Malocclusion: From Clinical Treatment Strategies to the Roadmap in Identifying the Genetic Bases of Development in Humans with the Support of the Collaborative Cross Mouse Population. Journal of Clinical Medicine, 12(15), 5148. https://doi.org/10.3390/jcm12155148

Vancouver

Lone IM, Zohud O, Midlej K, Proff P, Watted N, Iraqi FA. Skeletal Class II Malocclusion: From Clinical Treatment Strategies to the Roadmap in Identifying the Genetic Bases of Development in Humans with the Support of the Collaborative Cross Mouse Population. Journal of Clinical Medicine. 2023;12(15):5148. doi:10.3390/jcm12155148

BibTeX
@article{Lone2023,
  author = {Lone, Iqbal M and Zohud, Osayd and Midlej, Kareem and Proff, Peter and Watted, Nezar and Iraqi, Fuad A},
  title = {Skeletal Class II Malocclusion: From Clinical Treatment Strategies to the Roadmap in Identifying the Genetic Bases of Development in Humans with the Support of the Collaborative Cross Mouse Population},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {15},
  pages = {5148},
  doi = {10.3390/jcm12155148}
}
Kostenlos starten →